Literature DB >> 10643981

Inactivation of p53 and retinoblastoma family pathways in canine osteosarcoma cell lines.

R A Levine1, M A Fleischli.   

Abstract

Canine osteosarcoma (OS) has been used as a model system for the study of cancer biology and treatment despite the lack of information regarding its pathogenesis. Expression of tumor suppressor genes known to participate in malignant transformation were studied in five different OS cell lines. Each of the cell lines exhibited properties of transformed cells, and those that were tested grew in soft agarose and formed osteoid-containing tumors when injected subcutaneously into nude mice. p53 function was determined to be defective in each cell line as indicated by the lack of induction of p53-responsive genes, p21 and mdm2, following treatment with 5-fluorouracil. p53 mRNA and protein levels were elevated in three cell lines and were extremely low in two cell lines. p53 protein overexpression correlated with the presence of mutations within the DNA binding domain. Four cell lines appeared to contain normal retinoblastoma (Rb) mRNA and Rb protein and no detectable p16 mRNA or protein. In contrast, the remaining cell line contained high levels of p16 mRNA and protein and significantly reduced levels of Rb, p107, and p130 proteins. These results underscore the importance of inactivating p53 and Rb family pathways in canine OS and suggest that unlike human OS, cells derived from canine OS contain mutations that simultaneously inactivate all three Rb family members.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10643981     DOI: 10.1354/vp.37-1-54

Source DB:  PubMed          Journal:  Vet Pathol        ISSN: 0300-9858            Impact factor:   2.221


  20 in total

1.  Immunohistochemical detection of p53, PTEN, Rb, and p16 in canine osteosarcoma using tissue microarray.

Authors:  Duncan S Russell; Lauren Jaworski; William C Kisseberth
Journal:  J Vet Diagn Invest       Date:  2018-04-09       Impact factor: 1.279

2.  Canine tumor cross-species genomics uncovers targets linked to osteosarcoma progression.

Authors:  Melissa Paoloni; Sean Davis; Susan Lana; Stephen Withrow; Luca Sangiorgi; Piero Picci; Stephen Hewitt; Timothy Triche; Paul Meltzer; Chand Khanna
Journal:  BMC Genomics       Date:  2009-12-23       Impact factor: 3.969

3.  Canine osteosarcoma cells exhibit resistance to aurora kinase inhibitors.

Authors:  C M Cannon; J Pozniak; M C Scott; D Ito; B H Gorden; A J Graef; J F Modiano
Journal:  Vet Comp Oncol       Date:  2013-02-15       Impact factor: 2.613

Review 4.  Dog models of naturally occurring cancer.

Authors:  Jennie L Rowell; Donna O McCarthy; Carlos E Alvarez
Journal:  Trends Mol Med       Date:  2011-03-24       Impact factor: 11.951

5.  Establishment of a dog model for the p53 family pathway and identification of a novel isoform of p21 cyclin-dependent kinase inhibitor.

Authors:  Jin Zhang; Xiangling Chen; Michael S Kent; Carlos O Rodriguez; Xinbin Chen
Journal:  Mol Cancer Res       Date:  2009-01       Impact factor: 5.852

Review 6.  Canine sarcomas as a surrogate for the human disease.

Authors:  Daniel L Gustafson; Dawn L Duval; Daniel P Regan; Douglas H Thamm
Journal:  Pharmacol Ther       Date:  2018-03-09       Impact factor: 12.310

7.  Influence of genetic background on tumor karyotypes: evidence for breed-associated cytogenetic aberrations in canine appendicular osteosarcoma.

Authors:  Jaime F Modiano; Matthew Breen; Rachael Thomas; Huixia J Wang; Pei-Chien Tsai; Cordelia F Langford; Susan P Fosmire; Cristan M Jubala; David M Getzy; Gary R Cutter
Journal:  Chromosome Res       Date:  2009-04-01       Impact factor: 5.239

8.  The anti-tumour agent, cisplatin, and its clinically ineffective isomer, transplatin, produce unique gene expression profiles in human cells.

Authors:  Anne M Galea; Vincent Murray
Journal:  Cancer Inform       Date:  2008-06-10

Review 9.  Research models and mesenchymal/epithelial plasticity of osteosarcoma.

Authors:  Xiaobin Yu; Jason T Yustein; Jianming Xu
Journal:  Cell Biosci       Date:  2021-05-22       Impact factor: 7.133

10.  Disruption of chromosome 11 in canine fibrosarcomas highlights an unusual variability of CDKN2B in dogs.

Authors:  Jesús Aguirre-Hernández; Bruce S Milne; Chris Queen; Patricia C M O'Brien; Tess Hoather; Sean Haugland; Malcolm A Ferguson-Smith; Jane M Dobson; David R Sargan
Journal:  BMC Vet Res       Date:  2009-07-31       Impact factor: 2.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.